MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Enterprise Value of -$65.9 million for Q4 2025, up 36.4% on a YoY basis from -$48.3 million in Q4 2024, and down 344.25% quarter-over-quarter from -$14.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Enterprise Value (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Enterprise Value for 9 years, with the latest figure at -$65.9 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 36.4% year-over-year to -$65.9 million; the trailing twelve-month figure through Dec 2025 stood at -$65.9 million (up 36.4% YoY), and the FY2025 full-year result was -$65.9 million, up 36.4% from the prior year.
- Enterprise Value for Q4 2025 stood at -$65.9 million, down from -$14.8 million in the prior quarter.
- The five-year high for Enterprise Value was -$14.8 million in Q3 2025, with the low at -$199.4 million in Q1 2021.
- Historically, Enterprise Value has averaged -$102.8 million across 5 years, with a median of -$108.7 million in 2022.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 94.14% — and 2025, when it soared 88.13%.
- MeiraGTx Holdings' Enterprise Value stood at -$137.7 million in 2021, then climbed by 16.11% to -$115.5 million in 2022, then dropped by 13.1% to -$130.6 million in 2023, then climbed by 20.66% to -$103.7 million in 2024, then jumped by 36.4% to -$65.9 million in 2025.
- The last three Enterprise Value figures came in at -$65.9 million (Q4 2025), -$14.8 million (Q3 2025), and -$32.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | -65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.93 Mn |
| Sep 30, 2025 | -14.84 Mn |
| Jun 30, 2025 | -32.17 Mn |
| Mar 31, 2025 | -66.52 Mn |
| Dec 31, 2024 | -103.66 Mn |
| Sep 30, 2024 | -125.03 Mn |
| Jun 30, 2024 | -101.03 Mn |
| Mar 31, 2024 | -120.27 Mn |
| Dec 31, 2023 | -130.65 Mn |
| Sep 30, 2023 | -64.40 Mn |
| Jun 30, 2023 | -92.77 Mn |
| Mar 31, 2023 | -68.78 Mn |
| Dec 31, 2022 | -115.52 Mn |
| Sep 30, 2022 | -114.71 Mn |
| Jun 30, 2022 | -72.11 Mn |
| Mar 31, 2022 | -113.78 Mn |
| Dec 31, 2021 | -137.70 Mn |
| Sep 30, 2021 | -143.63 Mn |
| Jun 30, 2021 | -172.56 Mn |
| Mar 31, 2021 | -199.41 Mn |